𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Low dose intravenous bevacizumab for the treatment of anaemia in hereditary haemorrhagic telangiectasia

✍ Scribed by Suppressa Patrizia; Liso Arcangelo; Sabbà Carlo

Book ID
108677064
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
139 KB
Volume
152
Category
Article
ISSN
0007-1048

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effect of bevacizumab (Avastin) trea
The effect of bevacizumab (Avastin) treatment on epistaxis in hereditary hemorrhagic telangiectasia
✍ Jana Simonds; Frank Miller; Jess Mandel; Terence M. Davidson 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

## Abstract ## Objectives/Hypothesis: Determine the effectiveness of treating epistaxis in hereditary hemorrhagic telangiectasia (HHT) with potassium titanyl phosphate (KTP) laser cautery combined with submucosal injection of 100 mg of bevacizumab. ## Study Design: Retrospective pilot study. ##

Usefulness of a low-dose intravenous imm
Usefulness of a low-dose intravenous immunoglobulin regimen for the treatment of thrombocytopenia associated with AIDS
✍ Majluf-Cruz, Abraham; Luna-Castaños, Germán; Huitrón, Soledad; Nieto-Cisneros, L 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB 👁 2 views

Infection with the human immunodeficiency virus (HIV) frequently is complicated with thrombocytopenia (HIV-Thr) during all stages of the infection. The treatments for autoimmune thrombocytopenic purpura (ITP) are used in HIV-Thr; however, their effects upon the immune status of patients with acquire